Brain DeathDONORSNCT03179020
Donation Network to Optimize Organ Recovery Study
A study testing Checklist use in people with Brain Death and Organ Donation, run by Hospital Moinhos de Vento at 63 sites in Brazil.
Trial summary
This study consists in an cluster-randomized clinical trial involving near 60 Brazilian intensive care units (ICUs) with a high notification rate of potential donors of organs and tissues. Read more about this study
- Who is it for?
- Ages 14 to 90 years
- Conditions the study is for
- Brain Death, Organ Donation
- What is being tested?
- Checklist use
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,535 participants
- Where
- 63 sitesBrazil
- Study dates
- 20 Jun 2017to 28 Aug 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 90 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- For ICUs:
- Adults ICUs reporting at least 10 potential valid donors (without clinical contraindications for donation) per year
- For potential donor:
- Age of 14 years or older
- Suspected brain death after the first clinical test
Who cannot join
- For ICUs:
- Coronary units, intermediate units, emergency services
- ICUs that use checklist for the management of the potential donors
- For potential donors:
- Age >90 years
- HIV
Show all 15Show fewer
- Metastatic cancer
- Uncontrolled sepsis
- Acute hepatitis
- Malaria
- Acute viral infections
- Cryptococcal meningoencephalitis and prion diseases
- Active tuberculosis treated less than 2 months
- Colonization of the donor by bacteria without any option of antibiotic treatment
- History of breast tumor, melanoma, soft tissue sarcoma or hematologic neoplasia, WHO Group 3 primary tumors
Trial locations and contacts
63 sites in 1 country.
63 sites in 1 country
Brazil63 sites
Hospital de Urgência de Sergipe
Aracaju, Sergipe
Hospital Norte Paranaense
Arapongas, Paraná
Hospital das Clinicas das Minas Gerais
Belo Horizonte, Minas Gerais
Hospital João XXIII Fundação Hospitalar do Estado de Minas Gerais
Belo Horizonte, Minas Gerais
Hospital Universitário Ciências Médicas
Belo Horizonte, Minas Gerais
Santa Casa de Belo Horizonte
Belo Horizonte, Minas Gerais
Hospital das Clínicas de Botucatu
Botucatu, São Paulo
Hospital Universitário São Francisco da Providência de Deus de Bragança Paulista
Bragança Paulista, São Paulo
Hospital de Base do Distrito Federal
Brasília, Federal District
Hospital e Maternidade Angelina Caron
Campina Grande do Sul, Paraná, 83430-000
Santa Casa de Campo Grande
Campo Grande, Mato Grosso do Sul
Hospital Nossa Senhora do Rocio de Campo Largo
Campo Largo, Paraná
Hospital de Canoas
Canoas, Rio Grande do Sul
Hospital Universitário de Cascavel do Oeste do Paraná
Cascavel, Paraná
Hospital Geral Cleriston Andrade
Feira de Santana, Estado de Bahia
Hospital Geral de Fortaleza
Fortaleza, Ceará
Hospital Insituto Dr José Frota
Fortaleza, Ceará
Hospital Municipal Padre Germano Lauk
Foz do Iguaçu, Paraná, 85864-380
Hospital de Urgência de Goiânia
Goiânia, Goiás
Hospital São Vicente de Paulo Guarapuava
Guarapuava, Paraná
Alberto Urquiza Wanderley - Unimed João Pessoa
João Pessoa, Paraíba
Hospital Regional do Cariri
Juazeiro do Norte, Ceará
Hospital Bruno Born
Lajeado, Rio Grande do Sul
Hospital Evangélico de Londrina
Londrina, Paraná
Hospital Universitário Regional do Norte do Paraná
Londrina, Paraná
Hospital Geral Prof. Osvaldo Brandão Vilela
Maceió, Alagoas
Hospital de Pronto Socorro Dr. João Lúcio Pereira Machado
Manaus, Amazonas
Hospital Santa Rita de Maringá
Maringá, Paraná
Hospital Universitário de Maringá
Maringá, Paraná
Irmandade Santa Casa de Misericórdia de Maringá
Maringá, Paraná
Hospital Regional Tarcisio de Vasconcelos Maia
Mossoró, Ceará
Hospital Geral de Nova Iguaçu
Nova Iguaçu, Rio de Janeiro
Hospital São Vicente de Paulo
Passo Fundo, Rio Grande do Sul
Hospital Universitário São Francisco de Paula
Pelotas, Rio Grande do Sul
Hospital de Ensino Doutor Washington Antônio de barros
Petrolina, Pernambuco
Hospital Bom Jesus de Ponta Grossa
Ponta Grossa, Paraná
Hospital Universitario Regional dos Campos Gerais
Ponta Grossa, Paraná
Hospital Cristo Redentor
Porto Alegre, Rio Grande do Sul
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul
Hospital de Pronto Socorro de Porto Alegre
Porto Alegre, Rio Grande do Sul
Irmandade da Santa Casa de Porto Alegre
Porto Alegre, Rio Grande do Sul
Hospital de Pronto Socorro João Paulo II
Porto Velho, Rondônia
Hospital Municipal Irmã Dulce
Praia Grande, São Paulo
Hospital da Restauração
Recife, Pernambuco
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
Ribeirão Preto, São Paulo
Hospital das Clínicas de Rio Branco
Rio Branco, Acre
Hospital de Urgência e Emergência de Rio Branco
Rio Branco, Acre
Hospital Estadual Getúlio Vargas
Rio de Janeiro
Casa de Saúde de Santos
Santos, São Paulo
Hospital de Base de São José do Rio Preto
São José do Rio Preto, São Paulo
Hospital Dr Carlos Macieira
São Luís, Maranhão
Socorrão I - Hospital Municipal Djalma Marques
São Luís, Maranhão
Hospital Beneficência Portuguesa de São Paulo
São Paulo
Hospital Geral de Taipas
São Paulo
Hospital Paulistano
São Paulo
Hospital São Paulo
São Paulo
Irmandade da Santa Casa de Misericórdia de São Paulo
São Paulo
Hospital Regional Norte
Sobral, Ceará
Santa Casa de Misericórdia de Sobral
Sobral, Ceará
Irmandade Santa Casa de Misericórdia de Sorocaba
Sorocaba, São Paulo
Hospital Regional do Vale do Paraíba
Taubaté, São Paulo
Hospital Bom Jesus de Toledo
Toledo, Paraná
Hospital Estadual de Urgência e Emergência de Vitória
Vitória, Espírito Santo
About this study
Official title: Cluster Randomized Trial Evaluating the Implementation of a Evidence Based Checklist for the Management of Potential Organ Donors
This study consists in an cluster-randomized clinical trial involving near 60 Brazilian intensive care units (ICUs) with a high notification rate of potential donors of organs and tissues. ICUs will be randomized in a 1:1 ratio to manage potential organ donors through the use of a evidence-based checklist or to manage potential organ donors according usual care. The primary outcome is the rate of losses of potential donors due to cardiac arrest. Secondary outcome measures include number of effective organ donors and number of organs recovery per effective donor. The first subject was enrolled on June 20, 2018.
- Conditions
- Brain Death, Organ Donation
- Being tested
- Checklist use, Usual care
- Keywords
- Intensive Care Units, Brain Death, Organ Donation, Family interview
- Medical subject headings
- Brain Death
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Checklist useOther
Management of the potential donor guided by the use of an evidence-based checklist. This checklist is based on main recommendations of the Brazilian guideline for the management of potential multiple organ donors.
Usual careOther
Management of the potential donor according usual care.
| Study group | Role | What they receive |
|---|---|---|
| Checklist ICUs | Experimental | Management of the potential donor guided by the use of an evidence-based checklist. This checklist is based on main recommendations of the Brazilian guideline for the management of potential multiple organ donors. Receives: Other: Checklist use |
| Usual Care ICUs | Active comparator | Management of the potential donor according usual care. Receives: Other: Usual care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Losses of potential donors due to cardiac arrest
Proportion of losses of potential donors due to cardiac arrest
Measured: This event will be evaluated from the date of study subject enrollment until the date of organ recovery or end of brain death protocol (for cases of family refusal or contraindications to organ recovery) assessed up to 14 days
Secondary outcomes (2)
Effective organ donor
Proportion of Effective organ donors
Measured: This event will be evaluated from the date of study subject enrollment until the date of organ recovery or end of brain death protocol (for cases of family refusal or contraindications to organ recovery) assessed up to 14 days
Organ recovery per effective donor
Number of organs recovery per effective donor
Measured: This event will be evaluated from the date of study subject enrollment until the date of organ recovery assessed up to 14 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jun 2017
- Study start20 Jun 2017
- Primary completion28 Aug 2019
- Study completion28 Aug 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Brain DeathStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- In the present study ICUs will be randomized to manage potential organ donors through the use of a evidence-based checklist or to manage potential organ donors according usual care.
- Masking
- None (open label)
- Enrolment
- 1,535 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital Moinhos de Vento
- Sponsor type
- University, hospital or other
- Collaborators
- Ministry of Health, Brazil
- Responsible party
- Sponsor
- Investigators
- Glauco Westphal, MD, PhD, Principal investigator, Hospital Moinhos de VentoRegis G Rosa, MD, PhD, Study director, Hospital Moinhos de Vento
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03179020
- Sponsor's protocol ID
- DONORS Study
- Acronym
- DONORS
- Status last verified
- Oct 2020
- First submitted
- 23 Mar 2017
- Last updated
- 2 Nov 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Publications
Westphal GA, Robinson CC, Giordani NE, Teixeira C, Rohden AI, Dos Passos Gimenes B, Guterres CM, Madalena IC, Andrighetto LV, Souza da Silva S, Barbosa da Silva D, Sganzerla D, Cavalcanti AB, Franke CA, Bozza FA, Machado FR, de Andrade J, Pontes Azevedo LC, Schneider S, Orlando BR, Grion CMC, Bezerra FA, Roman FR, Leite FO Jr, Ferraz Siqueira IL, Oliveira JFP, de Oliveira LC Jr, de Melo MFRB, Leal PBGP, Diniz PC, Moraes RB, Salomao Pontes DF, Araujo Queiroz JE, Hammes LS, Meade MO, Rosa RG, Falavigna M; DONORS (Donation Network to Optimize Organ Recovery Study) Investigators and the BRICNet (Brazilian Research in Intensive Care Network). Evidence-Based Checklist to Delay Cardiac Arrest in Brain-Dead Potential Organ Donors: The DONORS Cluster Randomized Clinical Trial. JAMA Netw Open. 2023 Dec 1;6(12):e2346901. doi: 10.1001/jamanetworkopen.2023.46901.
PubMed 38095899Giordani NE, Robinson CC, Westphal GA, Rosa RG, Sganzerla D, Cavalcanti AB, Machado FR, Azevedo LCP, Bozza FA, Teixeira C, de Andrade J, Franke CA, Guterres CM, Madalena IC, Rohden AI, da Silva SS, Andrighetto LV, Rech GS, Gimenes BDP, Hammes LS, Pontes DFS, Meade MO, Falavigna M. Statistical analysis plan for a cluster-randomised trial assessing the effectiveness of implementation of a bedside evidence-based checklist for clinical management of brain-dead potential organ donors in intensive care units: DONORS (Donation Network to Optimise Organ Recovery Study). Trials. 2020 Jun 17;21(1):540. doi: 10.1186/s13063-020-04457-1.
PubMed 32552839Westphal GA, Robinson CC, Biasi A, Machado FR, Rosa RG, Teixeira C, de Andrade J, Franke CA, Azevedo LCP, Bozza F, Guterres CM, da Silva DB, Sganzerla D, do Prado DZ, Madalena IC, Rohden AI, da Silva SS, Giordani NE, Andrighetto LV, Benck PS, Roman FR, de Melo MFRB, Pereira TB, Grion CMC, Diniz PC, Oliveira JFP, Mecatti GC, Alves FAC, Moraes RB, Nobre V, Hammes LS, Meade MO, Nothen RR, Falavigna M; DONORS (Donation Network to Optimise Organ Recovery Study) Investigators and the BRICNet. DONORS (Donation Network to Optimise Organ Recovery Study): Study protocol to evaluate the implementation of an evidence-based checklist for brain-dead potential organ donor management in intensive care units, a cluster randomised trial. BMJ Open. 2019 Jun 25;9(6):e028570. doi: 10.1136/bmjopen-2018-028570.
PubMed 31243035
Study at a glance
From the registry record, last updated by the sponsor on 2 Nov 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cluster Randomized Trial Evaluating the Implementation of a Evidence Based Checklist for the Management of Potential Organ Donors
- ClinicalTrials.gov ID
- NCT03179020
- Acronym / sponsor ID
- DONORS / DONORS Study
- Conditions
- Brain Death, Organ Donation
- Keywords
- Intensive Care Units, Brain Death, Organ Donation, Family interview
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,535 participants (actual)
- Lead sponsor
- Hospital Moinhos de VentoUniversity, hospital or other
- Collaborators
- Ministry of Health, Brazil
- Study start
- 20 Jun 2017 (actual)
- Primary completion
- 28 Aug 2019 (actual)
- Study completion
- 28 Aug 2019 (actual)
- First posted
- 7 Jun 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study consists in an cluster-randomized clinical trial involving near 60 Brazilian intensive care units (ICUs) with a high notification rate of potential donors of organs and tissues. ICUs will be randomized in a 1:1 ratio to manage potential organ donors through the use of a evidence-based checklist or to manage potential organ donors according usual care. The primary outcome is the rate of losses of potential donors due to cardiac arrest. Secondary outcome measures include number of effective organ donors and number of organs recovery per effective donor. The first subject was enrolled on June 20, 2018.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- In the present study ICUs will be randomized to manage potential organ donors through the use of a evidence-based checklist or to manage potential organ donors according usual care.
| Arm | Type | Receives |
|---|---|---|
| Checklist ICUs | Experimental | Other: Checklist useManagement of the potential donor guided by the use of an evidence-based checklist. This checklist is based on main recommendations of the Brazilian guideline for the management of potential multiple organ donors. |
| Usual Care ICUs | Active comparator | Other: Usual careManagement of the potential donor according usual care. |
Who may qualify
- Ages
- 14 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Adults ICUs reporting at least 10 potential valid donors (without clinical contraindications for donation) per year
- Age of 14 years or older
- Suspected brain death after the first clinical test
Key exclusion criteria (15 listed)
- Coronary units, intermediate units, emergency services
- ICUs that use checklist for the management of the potential donors
- Age >90 years
- HIV
- Metastatic cancer
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Checklist useManagement of the potential donor guided by the use of an evidence-based checklist. This checklist is based on main recommendations of the Brazilian guideline for the management of potential multiple organ donors. | Other | Checklist ICUs |
| Usual careManagement of the potential donor according usual care. | Other | Usual Care ICUs |
Primary outcome
Losses of potential donors due to cardiac arrest
Time frame: This event will be evaluated from the date of study subject enrollment until the date of organ recovery or end of brain death protocol (for cases of family refusal or contraindications to organ recovery) assessed up to 14 days
Proportion of losses of potential donors due to cardiac arrest
2 secondary outcomes
Effective organ donor
Time frame: This event will be evaluated from the date of study subject enrollment until the date of organ recovery or end of brain death protocol (for cases of family refusal or contraindications to organ recovery) assessed up to 14 days
Organ recovery per effective donor
Time frame: This event will be evaluated from the date of study subject enrollment until the date of organ recovery assessed up to 14 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Nov 2020.
- Derived from this study: PubMed 38095899Westphal GA, Robinson CC, Giordani NE, Teixeira C, Rohden AI, Dos Passos Gimenes B, Guterres CM, Madalena IC, Andrighetto LV, Souza da Silva S, Barbosa da Silva D, Sganzerla D, Cavalcanti AB, Franke CA, Bozza FA, Machado FR, de Andrade J, Pontes Azevedo LC, Schneider S, Orlando BR, Grion CMC, Bezerra FA, Roman FR, Leite FO Jr, Ferraz Siqueira IL, Oliveira JFP, de Oliveira LC Jr, de Melo MFRB, Leal PBGP, Diniz PC, Moraes RB, Salomao Pontes DF, Araujo Queiroz JE, Hammes LS, Meade MO, Rosa RG, Falavigna M; DONORS (Donation Network to Optimize Organ Recovery Study) Investigators and the BRICNet (Brazilian Research in Intensive Care Network). Evidence-Based Checklist to Delay Cardiac Arrest in Brain-Dead Potential Organ Donors: The DONORS Cluster Randomized Clinical Trial. JAMA Netw Open. 2023 Dec 1;6(12):e2346901. doi: 10.1001/jamanetworkopen.2023.46901.
- Derived from this study: PubMed 32552839Giordani NE, Robinson CC, Westphal GA, Rosa RG, Sganzerla D, Cavalcanti AB, Machado FR, Azevedo LCP, Bozza FA, Teixeira C, de Andrade J, Franke CA, Guterres CM, Madalena IC, Rohden AI, da Silva SS, Andrighetto LV, Rech GS, Gimenes BDP, Hammes LS, Pontes DFS, Meade MO, Falavigna M. Statistical analysis plan for a cluster-randomised trial assessing the effectiveness of implementation of a bedside evidence-based checklist for clinical management of brain-dead potential organ donors in intensive care units: DONORS (Donation Network to Optimise Organ Recovery Study). Trials. 2020 Jun 17;21(1):540. doi: 10.1186/s13063-020-04457-1.
- Derived from this study: PubMed 31243035Westphal GA, Robinson CC, Biasi A, Machado FR, Rosa RG, Teixeira C, de Andrade J, Franke CA, Azevedo LCP, Bozza F, Guterres CM, da Silva DB, Sganzerla D, do Prado DZ, Madalena IC, Rohden AI, da Silva SS, Giordani NE, Andrighetto LV, Benck PS, Roman FR, de Melo MFRB, Pereira TB, Grion CMC, Diniz PC, Oliveira JFP, Mecatti GC, Alves FAC, Moraes RB, Nobre V, Hammes LS, Meade MO, Nothen RR, Falavigna M; DONORS (Donation Network to Optimise Organ Recovery Study) Investigators and the BRICNet. DONORS (Donation Network to Optimise Organ Recovery Study): Study protocol to evaluate the implementation of an evidence-based checklist for brain-dead potential organ donor management in intensive care units, a cluster randomised trial. BMJ Open. 2019 Jun 25;9(6):e028570. doi: 10.1136/bmjopen-2018-028570.
- Individual participant dataSharing planned: Undecided. The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Related trials for Brain Death
RecruitingPhase 2
A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
Recurrent Glioblastoma
Not yet recruiting
Miniature In-line Respirator
Brain Death, Respiration, Artificial
Not yet recruitingPhase 3
Cilostazol for Prevention of Recurrent Stroke Trial
Stroke Recurrence, Myocardial Infarction
Recruiting
Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Meconium Exposure
Neonatal Respiratory Distress Related Conditions, Meconium
Recruiting
Study of the Link Between Structural Alterations in the Hypothalamus and Cardiac Dysautonomia in Drug-resistant Epilepsy
Epilepsy, Hypothalamus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Glauco Westphal, MD, PhD principal investigator
Hospital Moinhos de Vento
Regis G Rosa, MD, PhD study director
Hospital Moinhos de Vento
63 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Checklist use in people with Brain Death and Organ Donation, run by Hospital Moinhos de Vento at 63 sites in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 63 sites in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Losses of potential donors due to cardiac arrest (time frame: This event will be evaluated from the date of study subject enrollment until the date of organ recovery or end of brain death protocol (for cases of family refusal or contraindications to organ recovery) assessed up to 14 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03179020, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2020.